← All trials

NCT06059014

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Nov 9, 2023
Primary completion
Apr 30, 2026
Completion date
Apr 30, 2027
First posted
Sep 28, 2023
Last posted
Nov 18, 2023
Enrollment
48
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.